Sunil Shaunak

Title: Innovations and Contributions of Inventor Sunil Shaunak

Introduction

Sunil Shaunak is a prominent inventor based in Greater London, GB. With a focus on advanced biomedical applications, he holds two patents that showcase his innovative contributions to the field of glycodendrimers.

Latest Patents

Sunil Shaunak's latest patents include:

1. **Glycodendrimers of Polypropyletherimine** - This invention involves a glycodendrimer comprising a non-toxic polypropyletherimine core that supports an average range of 9 to 64 terminal carboxylic acid groups. It is conjugated with 2 to 8 amino sugars or a sulphate amino sugar selected from various sugars, including glucosamine and galactosamine. The invention also encompasses defined populations comprising these glycodendrimer molecules, pharmaceutical compositions, processes for preparation, and their therapeutic uses.

2. **Glycodendrimers Having Biological Activity** - This invention relates to new anionic glycodendrimers exhibiting novel biological activity. Sunil's work includes processes for their preparation and their applications in medicine and veterinary medicine.

Career Highlights

Sunil Shaunak is affiliated with Imperial Innovations Limited, where he applies his expertise in developing innovative biomedical solutions. His two patents reflect his commitment to enhancing pharmaceutical formulations and improving therapeutic outcomes.

Collaborations

During his career, Sunil has collaborated with notable coworkers, including Ian Alfred Teo and Elisabetta Gianasi. Together, they contribute to advancements in the field, fostering innovation and progress within their projects.

Conclusion

Sunil Shaunak stands out as an influential inventor, with his work significantly impacting the development of glycodendrimers. His patents not only reflect his innovative spirit but also demonstrate the potential for these inventions to revolutionize medical applications and improve patient care.